v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating expenses      
Research and development expenses $ 105,581 $ 51,858 $ 13,280
Selling, general and administrative expenses 23,104 32,856 4,899
New Warrants expenses 1,863 104,776 0
Loss from operations (130,549) (189,490) (18,179)
(Loss)/gain from change in fair value of derivative liabilities (10,403) 9,548 0
Financial investment income 11,672 5,073 0
Interest income from related party loan 4,385 1,650 0
Other (loss)/gain, net (945) 122 (77)
Interest expense (252) 0 0
Loss before income taxes (126,091) (173,097) (18,256)
Income tax expense 1,568 933 0
Net loss $ (127,658) $ (174,030) $ (18,256)
Weighted-average number of shares outstanding – basic (in shares) 275,763 254,131 220,000
Weighted-average number of shares outstanding – diluted (in shares) 275,763 254,131 220,000
Net loss per share basic (in dollars per share) $ (0.46) $ (0.68) $ (0.08)
Net loss per share diluted (in dollars per share) $ (0.46) $ (0.68) $ (0.08)

Source